American Business Times
SEE OTHER BRANDS

The best business and economy news from the United States

American Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.

Press releases published on May 29, 2025

Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals

Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals

ROCKVILLE, Md., May 29, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals is expanding its partnership with TV personality and sports reporter Jay Glazer in a new content series featuring his wife, Rosie Glazer. The series, which launches its first episode …

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …

atai Life Sciences to Participate in Upcoming Investor Conferences

atai Life Sciences to Participate in Upcoming Investor Conferences

NEW YORK and BERLIN, May 29, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences  (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, …

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

Vaxart’s Founder and Chief Scientific Officer Provides Video Update to Stockholders

Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 Company Corrects Record on Common Misconceptions Regarding the Reverse Stock Split Proposal SOUTH SAN …

YIKES, A BOLD BETTER-FOR-YOU HOT CHIP, SET TO HIT SHELVES IN JUNE 2025

YIKES, A BOLD BETTER-FOR-YOU HOT CHIP, SET TO HIT SHELVES IN JUNE 2025

YIKES WILL HIT THE SHELVES IN JUNE, A BOLD AND BETTER FOR YOU ROLLED TORTILLA CHIP FLAVOR PACKED WITH A VARIETY OF FLAVORS TO CHOOSE FROM MIAMI, FL, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- Introducing YIKES: A Bold, Better-For-You Hot Chip Set …

Elite Roof and Solar Earns 2025 GAF Master Elite® 3-Star President's Club Award for Third Consecutive Year

Elite Roof and Solar Earns 2025 GAF Master Elite® 3-Star President's Club Award for Third Consecutive Year

Davidson roofing company wins prestigious award for the second year in a row. DAVIDSON, NC, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- Elite Roof and Solar, a trusted leader in roofing and solar services across the Carolinas, announced today that …

Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client

Reflect Scientific Completes $550,000 Next-Generation Freezer Installation for Pharmaceutical Client

OREM, Utah, May 29, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leader in ultra-low temperature freezer technology, today announced the successful completion of a major installation project valued at $550,000. The deployment, which …

Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference

Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Septerna to Present at Jefferies Global Healthcare Conference

Septerna to Present at Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief Executive …

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference

WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its presentation at the …

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities

EVANSTON, Ill., May 29, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that highly-regarded industry leaders Robert Rouse and Jason Stephani …

Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain

Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain

CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain The Company’s virology study further confirmed the previous structural and in vitro data that revealed the binding of CC-42344 to PB2 protein of the …

La Rosa Holdings Corp. Reports 34% Year-Over-Year Increase in Revenue to $17.5 Million for First Quarter of 2025  

La Rosa Holdings Corp. Reports 34% Year-Over-Year Increase in Revenue to $17.5 Million for First Quarter of 2025  

Gross Profit Increased 32% Year-Over-Year to $1.5 Million in Q1 2025 Residential Real Estate Services Revenue Increased 39% to $14.3 Million in Q1 2025 vs Q1 2024 CELEBRATION, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“ …

Trident Resources Announces Appointment of Scott Broughton as Strategic Advisor

Trident Resources Announces Appointment of Scott Broughton as Strategic Advisor

Vancouver, BC, May 29, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce the appointment of Mr. Scott Broughton as a Strategic Advisor. Scott Broughton is an accomplished mine …

Maxus Mining Announces Listing on the Frankfurt Stock Exchange Under the Symbol R7V

Maxus Mining Announces Listing on the Frankfurt Stock Exchange Under the Symbol R7V

VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- Maxus Mining Inc. (“Maxus” or the “Company”) (CSE: MAXM | FRA: R7V), is pleased to announce that its common shares are now trading on the Frankfurt Stock Exchange (“FSE”) under the symbol “R7V”, …

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced …

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune …

Replimune to Present at the 2025 Jefferies Global Healthcare Conference

Replimune to Present at the 2025 Jefferies Global Healthcare Conference

WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will …

Q.E.P. Co., Inc. Reports Fiscal 2025 Full Year Financial Results

Q.E.P. Co., Inc. Reports Fiscal 2025 Full Year Financial Results

BOCA RATON, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Q.E.P. CO., INC. (OTCQX: QEPC) (the “Company” or “QEP”) today reported its financial results for the full fiscal year ended February 28, 2025. These results follow the completion of a portfolio …

Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer

Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer

PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced the appointment …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service